BRCA1 and BRCA2 are important for DNA double-strand break repair by homologous
recombination 1 , and mutations in these genes predispose to breast and other cancers 2 . Poly(…

IN Western Europe and the United States approximately 1 in 12 women develop breast cancer.
A small proportion of breast cancer cases, in particular those arising at a young age, are …

Background The inhibition of poly(adenosine diphosphate [ADP]–ribose) polymerase (PARP)
is a potential synthetic lethal therapeutic strategy for the treatment of cancers with specific …

A newly described coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
which is the causative agent of coronavirus disease 2019 (COVID-19), has …

Recently, RAD51C mutations were identified in families with breast and ovarian cancer 1 .
This observation prompted us to investigate the role of RAD51D in cancer susceptibility. We …

Genomic instability is one of the most pervasive characteristics of tumour cells and is probably
the combined effect of DNA damage, tumour-specific DNA repair defects, and a failure to …

Members of the Rho family of small guanosine triphosphatases (GTPases) regulate the
organization of the actin cytoskeleton; Rho controls the assembly of actin stress fibers and focal …

Background Prostate cancer is a heterogeneous disease, but current treatments are not based
on molecular stratification. We hypothesized that metastatic, castration-resistant prostate …

PARP inhibitors (PARPi), a cancer therapy targeting poly(ADP-ribose) polymerase, are the
first clinically approved drugs designed to exploit synthetic lethality, a genetic concept …

Germline mutations in the BRCA1, BRCA2 and Fanconi anaemia genes confer cancer
susceptibility, and the proteins encoded by these genes have distinct functions in related DNA-…